HOME >> MEDICINE >> NEWS
Beta-blockers protect brain during bypass surgery

DURHAM, N.C. -- When given prior to or during coronary artery bypass surgery, a class of heart drugs known as beta-blockers provides significant protection to the brain and its functions, according to a new study by Duke University Medical Center researchers.

"Data is rapidly accumulating that every patient undergoing bypass surgery -- with a few exceptions -- should be given beta-blockers for bypass surgery," said Mark Newman, M.D., Duke chairman of anesthesiology and lead investigator of Duke's Perioperative Organ Protection Consortium. "Since only about 60 percent of bypass patients nationwide are given beta-blockers for surgery, there is certainly much room for improvement in this area."

The results of the Duke analysis were published today (June 13, 2002) in the Journal of Cardiothoracic and Vascular Anesthesia. The research was supported by the National Institutes of Health and the American Heart Association.

In their study, the researchers analyzed the medical records of 2,575 patients who underwent bypass surgery at Duke over a three-year period. They found that only 3.9 percent of the patients receiving beta-blockers suffered adverse neurological events, compared to 8.2 percent of those not on the drugs. The adverse neurological effects of surgery measured were stroke, coma, transient ischemic attacks (TIA), also known as "mini-strokes," and encephalopathy.

For the most severe of the events, stroke and coma, the beneficial effect of beta-blockers was even more striking -- a 1.9 percent rate of adverse effects for those taking the drugs and 4.3 percent for those who did not.

These results follow an earlier study by a different Duke team (May 2002, Journal of the American Medical Association) that showed that beta-blockers given prior to or during bypass surgery reduced the 30-day mortality rate of the procedure from 3.4 percent to 2.8 percent. More than 570,000 of the heart
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
12-Jun-2002


Page: 1 2 3

Related medicine news :

1. Beta-blockers may help broader group of patients with heart problems
2. Beta-blockers after heart surgery show double benefits
3. Beta-blockers improve outcomes of bypass surgery
4. New study in Nature demonstrates protection against cell death during heart attack
5. Simple intervention encourages sun protection behaviors
6. Red wine protects the heart
7. Sunflower seed oil can protect low birth weight babies from infection
8. Physical activity linked to protection from Parkinsons disease
9. Component of green tea protects injured livers in mice
10. Study shows protective equipment not very effective for rugby players
11. Least protection offered to those most at risk of sudden cardiac death

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Beta blockers protect brain during bypass surgery

(Date:4/21/2015)... 2015 Carinsurancesavings.biz has released a new blog ... surveillance and explaining the impact on a uto insurance ... and supervised may be eligible for advantageous auto insurance discounts. ... simple and efficient way. This will also help them get ... simple way. , Finding low cost coverage is no longer ...
(Date:4/21/2015)... 2015 Optimity Advisors ( Optimity), ... firm that helps clients in complex industries navigate ... the Association of Community Affiliated Plans ... represents 58 local, not-for-profit, community-affiliated Safety Net Health ... people primarily enrolled in public or state-sponsored coverage ...
(Date:4/21/2015)... CO (PRWEB) April 21, 2015 ... Management , a new knowledge management solution that ... and publishing of policies and procedures. With Quark ... create reusable content that is easy to save, ... is susceptible to risk and compliance issues. Examples ...
(Date:4/21/2015)... When a bandage sticks to an injury ... to solve this problem two inventors from Festus, Mo., ... bandage helps a cut, burn, abrasion or wound heal ... exposure. The bandage is easy to use, versatile and ... submitted to the St. Louis office of InventHelp. It ...
(Date:4/21/2015)... Ill. (PRWEB) April 21, 2015 The ... the late cosmetic dermatologist Fredric S. Brandt, M.D., by ... Dr. Brandt, an ASDS member since 1982, died earlier ... The funds are designed to provide opportunities for ASDS ... field of cosmetic dermatology that Dr. Brandt held so ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4
(Date:4/21/2015)... 21, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that the abstract describing ... from the Phase 2 clinical trial of the Company,s ... selected for an oral presentation at the 2015 American ... held in Chicago, Illinois May ...
(Date:4/20/2015)... 2015  Following is the daily "Profile America" feature ... MEDICINE Profile America — ... insulin —became available for general use this month in ... from diabetes. Insulin is a hormone produced by the ... in the human body. It was first isolated the ...
(Date:4/20/2015)... Ireland , April 20, 2015 ... that Charles M. Mayr , Chief Communications ... due to health reasons.  In conjunction with Mayr,s ... will assume the role of Chief Communications Officer, ... Kelly served as Senior Vice President, Chief Communications ...
Breaking Medicine Technology:Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3U.S. Census Bureau Daily Feature for April 21 2Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3
Cached News: